MustGrow Biologics Corp.
MGRO.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3,003.65% | -58.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3,003.65% | -58.52% | |||
| Cost of Revenue | 1,973.39% | 74.92% | |||
| Gross Profit | 1,302.62% | -118.95% | |||
| SG&A Expenses | 96.27% | -55.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 311.84% | -39.37% | |||
| Operating Income | -13.80% | 36.11% | |||
| Income Before Tax | -31.88% | 29.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.88% | 29.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.88% | 29.68% | |||
| EBIT | -13.80% | 36.11% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -24.40% | 29.71% | |||
| Normalized Basic EPS | -24.76% | 29.53% | |||
| EPS Diluted | -24.40% | 29.71% | |||
| Normalized Diluted EPS | -24.76% | 29.53% | |||
| Average Basic Shares Outstanding | 5.88% | 0.00% | |||
| Average Diluted Shares Outstanding | 5.88% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||